Valuation: BOIRON

Market Cap 46Cr 53Cr 43Cr 39Cr 74Cr 5.07TCr 75Cr 504.68Cr 197.32Cr 2.54TCr 199.25Cr 194.93Cr 8.44TCr P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 41Cr 48Cr 39Cr 35Cr 66Cr 4.54TCr 67Cr 451.99Cr 176.72Cr 2.28TCr 178.45Cr 174.57Cr 7.56TCr EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week-3.64%
Current month-2.21%
1 month-2.21%
3 months-7.67%
6 months-10.02%
Current year-11.07%
1 week 26.5
Extreme 26.5
27.5
1 month 26.5
Extreme 26.5
27.5
3 years 20.5
Extreme 20.5
55.9
5 years 20.5
Extreme 20.5
55.9
10 years 20.5
Extreme 20.5
91.9
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.64%+22.12%-48.44% 53Cr
-0.85%-1.44%-10.60%-7.20% 1.32TCr
-1.45%-2.24%-32.41%-57.43% 497.78Cr
-1.44%-2.77%+3.16%-2.37% 491.29Cr
-0.82%-0.18%+6.80%-29.83% 420.12Cr
-1.69%-2.72%-18.35%-2.90% 358.73Cr
-0.65%-2.48%-5.25%+12.72% 339.56Cr
-1.96%-5.37%-7.58%-10.25% 334.93Cr
-0.56%-0.25%-13.63%-16.96% 248.76Cr
+2.56%+10.60%+3.45%-11.11% 180.55Cr
Average -0.76%-0.85%-5.23%-17.38% 466.14Cr
Weighted average by Cap. -0.97%-1.80%-9.00%-14.30%

Financials

2024 2025
Net sales 49Cr 56Cr 46Cr 42Cr 78Cr 5.4TCr 80Cr 536.82Cr 209.89Cr 2.7TCr 211.94Cr 207.34Cr 8.98TCr 50Cr 58Cr 47Cr 43Cr 81Cr 5.55TCr 82Cr 551.74Cr 215.72Cr 2.78TCr 217.83Cr 213.1Cr 9.23TCr
Net income 1.13Cr 1.31Cr 1.07Cr 96.88L 1.82Cr 125.5Cr 1.85Cr 12Cr 4.88Cr 63Cr 4.93Cr 4.82Cr 208.85Cr 3.26Cr 3.78Cr 3.07Cr 2.79Cr 5.24Cr 361.4Cr 5.33Cr 36Cr 14Cr 180.98Cr 14Cr 14Cr 601.41Cr
Net Debt -4.97Cr -5.76Cr -4.67Cr -4.25Cr -7.99Cr -550.66Cr -8.12Cr -55Cr -21Cr -275.75Cr -22Cr -21Cr -916.37Cr -4.79Cr -5.54Cr -4.5Cr -4.09Cr -7.69Cr -529.81Cr -7.82Cr -53Cr -21Cr -265.31Cr -21Cr -20Cr -881.67Cr
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
-
Date Price Change
14/26/14 €26.50 0.00%
13/26/13 €26.50 0.00%
12/26/12 €26.50 0.00%
11/26/11 €26.50 -0.75%
10/26/10 €26.70 -2.91%

Annual profits - Rate of surprise